Burning Rock Biotech Limited (BNR) Earnings History
Annual and quarterly earnings data from 2017 to 2024
Loading earnings history...
BNR EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
BNR Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 70.3% | -69.3% | -67.2% |
| 2023 | 67.6% | -124.5% | -121.6% |
| 2022 | 67.5% | -174.1% | -172.4% |
| 2021 | 71.7% | -156.9% | -156.9% |
| 2020 | 73.0% | -95.9% | -94.7% |
Download Data
Export BNR earnings history in CSV or JSON format
Free sign-in required to download data
Burning Rock Biotech Limited (BNR) Earnings Overview
As of May 8, 2026, Burning Rock Biotech Limited (BNR) reported trailing twelve-month net income of -$121M, reflecting +47.3% year-over-year growth. The company earned $-112.60 per diluted share over the past four quarters, with a net profit margin of -67.2%.
Looking at the long-term picture, BNR's historical earnings data spans multiple years. The company achieved its highest annual net income of -$131M in fiscal 2017.
Burning Rock Biotech Limited is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including EXAS (-$208M net income, -6.4% margin), GH (-$433M net income, -42.4% margin), NTRA (-$208M net income, -9.0% margin), BNR has room to improve margins relative to the peer group. Compare BNR vs EXAS →
BNR Earnings vs Peers
Earnings metrics vs comparable public companies
BNR Historical Earnings Data (2017–2024)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$347M | +47.0% | -$358M | $-33.67 | -67.2% | -69.3% |
| 2023 | -$654M | +32.7% | -$669M | $-63.84 | -121.6% | -124.5% |
| 2022 | -$971M | -21.9% | -$980M | $-93.47 | -172.4% | -174.1% |
| 2021 | -$797M | -95.6% | -$797M | $-76.45 | -156.9% | -156.9% |
| 2020 | -$407M | -141.9% | -$412M | $-68.76 | -94.7% | -95.9% |
| 2019 | -$168M | +5.2% | -$169M | $-142.30 | -44.1% | -44.3% |
| 2018 | -$177M | -35.2% | -$161M | $-103.82 | -85.0% | -77.3% |
| 2017 | -$131M | - | -$121M | $-102.02 | -118.1% | -108.7% |
See BNR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BNR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BNR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBNR — Frequently Asked Questions
Quick answers to the most common questions about buying BNR stock.
Is BNR growing earnings?
BNR EPS is $-112.60, with earnings growth accelerating to +47.3%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-121M.
What are BNR's profit margins?
Burning Rock Biotech Limited net margin is -67.2%, with operating margin at -69.3%. Below-average margins reflect competitive or cost pressures.
How consistent are BNR's earnings?
BNR earnings data spans 2017-2024. The accelerating earnings trend is +47.3% YoY. Historical data enables comparison across business cycles.